Newborn Screening Market Size and Forecasts (2020 – 2030)

Newborn Screening Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type (Reagents and Assay Kits, and Instruments), Technology [Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays and Enzymatic Assays, Pulse Oximetry Screening Technology, and Others], Test Type [Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test, and Others], End User (Hospitals and Clinics, and Diagnostic Laboratories), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry
Item ID: TIPHE100001294 Category: Tags: , ,

$3,185$5,985

Description

The global newborn screening market is expected to reach US$ 2.484 billion in 2030 from US$ 1.206 billion in 2022. The market is estimated to grow with a CAGR of 9.4% from 2022 to 2030.

The key factors driving the market include rising burden of congenital diseases and increasing prevalence of newborn disorders. However, lack of uniformity of newborn screening policies and procedures across the world and false positive and false negative results hinders the market growth.

Market Opportunities of Newborn Screening Market

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. The US FDA licensed the Kymriah gene therapy in 2017 for use in pediatric patients with a particular kind of acute lymphoblastic leukemia. During this therapy, a new gene that codes for a chimeric antigen receptor is inserted into the patient’s T cells, stimulating the altered T cells to go after and destroy the leukemic cells. Yescarta and Zynteglo are two more examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

Factors Hampering Newborn Screening Market

Variations regarding the list of conditions screened for in different countries result in non-uniformity in newborn screening policies and practices worldwide. A few nations screen for a comprehensive range of disorders, while others focus on a limited set. This difference creates barriers for companies developing screening tests and technologies, as they need to modify their products to specific markets, limiting economies of scale. Moreover, the lack of standardized protocols can result in inconsistent quality control and data collection practices. This leads to inaccuracies in screening results and difficulties in comparing data between regions, making it challenging for researchers and healthcare providers to assess the effectiveness of screening programs implemented in localities understudy. Additionally, the absence of universal standards complicates the regulatory landscape for companies operating in the newborn screening market, as they need to focus on complying with a complex web of regulations for seeking approvals in different countries, which can be time-consuming and expensive. The lack of uniformity can also hinder international collaborations and data sharing, limiting the potential of newborn screening research and technology development. Thus, the lack of uniformity in newborn screening policies and procedures limits the progress of the newborn screening market.

Newborn Screening Market: Segmental Overview

The newborn screening market, by product type, is segmented into reagents and assay kits and instruments. In 2022, the reagents and assay kits segment held a larger market share and is expected to grow at the fastest rate in the coming years. Different reagents and assay kits for newborn screening are categorized into DNA-based assays, immunoassays, and enzymatic assays. Various companies in the market have developed a range of reagents and assay kits specifically for neonatal screening. Firstly, Labsystems Diagnostics launched a fluorometric microplate-based assay for detecting phenylketonuria (PKU) in newborns based on phenylalanine content, as increasing the phenylalanine level in the baby can cause intellectual disability. All the reagent kits offered by the Company are manual modular systems or fully automated hands-off systems.

The newborn screening market, by technology, is segmented into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assays, pulse oximetry screening technology, and other technologies. In 2022, the pulse oximetry screening technology segment held the largest share of the market. Moreover, the immunoassays and enzymatic assays segment is expected to grow fastest during the coming years. Congenital heart disease (CCHD), one of the most common congenital disabilities, is a duct-dependent congenital heart disease. It may be detected during the prenatal and postnatal period, while it can be life-threatening if it goes undiagnosed and untreated in the neonatal period or infancy. Pulse oximetry screening is used to detect critical CCHD in infants. It is a painless, noninvasive, and cost-effective method of screening infants. The pulse oximeter screening determines the percentage of hemoglobin in the blood saturated with oxygen.

The newborn screening market, by test type, is segmented into dry blood spot tests, hearing screen tests, critical congenital heart disease tests, and other tests. In 2022, the blood spot test segment held the largest share of the market. The newborn screening market for the same segment is estimated to grow at a significant CAGR during 2022 -2030.

The newborn screening market, by end-user, is segmented into hospitals, clinics, and diagnostic laboratories. In 2022, the hospitals and clinics segment held a larger market share. However, the hospitals and clinics segment is estimated to grow at a CAGR during 2022-2030. healthcare provider performs newborn screening tests in a room or a newborn/nursery area at hospitals. The hospitals and clinics segment is projected to hold a larger share of the newborn screening market in the coming years as these facilities receive maximum patient footfall for newborn baby screening. Better facilities, and the availability of different treatment options and good nursing care under one roof attract patients toward these facilities for different diagnostic and therapeutic procedure.

Newborn Screening Market: Geographical Overview

The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities—laboratory automation has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren’t often present at the time of delivery. The Texas Department of Health and Human Services began screening newborns for Spinal Muscular Atrophy (SMA) in June 2021.

A few of the major primary and secondary sources referred to while preparing the report on the newborn screening market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Hospitals and Clinics Segment to Lead Global Newborn Screening Market During 2022–2030

According to our new research study on “Newborn Screening Market Forecast To 2030 – Global Analysis – by Product Type, Technology, Test Type, and End User,” the newborn screening market is expected to grow from US$ 1,206.74 million in 2022 to US$ 2,484.16 million by 2030; it is estimated to record a CAGR of 9.4% from 2022–2030. Key factors driving the newborn screening market growth are the rising burden of congenital diseases, rising funding from government sectors for newborn screening, and the increasing prevalence of newborn disorders.

The newborn screening market, by end user, is segmented into hospitals and clinics, and diagnostic laboratories. The hospitals and clinics segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR in the newborn screening market during the forecast period. Newborn screening is the process by which newborn babies are screened after birth for disorders that may cause severe illness or death without proper detection and intervention. Usually, a healthcare provider performs newborn screening tests in a room or a newborn/nursery area at hospitals. The hospitals and clinics segment is projected to hold a larger share of the newborn screening market in the coming years as these facilities receive maximum patient footfall for newborn baby screening. Better facilities, and the availability of different treatment options and good nursing care under one roof attract patients toward these facilities for different diagnostic and therapeutic procedures. Government schemes, awareness programs, and financial aid attract more patients to visit hospitals and clinics for diagnosis and treatments. Many hospitals and clinics are a vital part of health system development efforts across the world, resulting in a continuous rise in the number of hospitals and clinics every year. They play an important role in offering support to other healthcare providers. The hospital staff are well trained to tackle all emergencies and provide balanced neonatal care.

Asia Pacific is the fastest-growing region of the global newborn screening market in 2022. The projected growth of the market in this region can be associated with the high number of newborn births, the soaring prevalence of congenital diseases, rising awareness regarding early diagnosis of birth defects in newborns, and the presence of organizations working toward offering better solutions for newborn screening.

Screening of newborns in Asia -Pacific is gaining traction; government agencies in China, India, and other countries need to implement newborn screening programs owing to the high birth rate. According to the United Nations International Children’s Emergency Fund (UNICEF), 67,385 babies are born in India each day, accounting for one-sixth of childbirths recorded globally in a day. In addition, India has become the most populated nation; as per Worldmapper, ~23 million babies were born in 2022, followed by China with the birth of 10 million babies. With the constantly soaring birth rate, the focus on infant care is increasing in India, as well as in other countries in Asia -Pacific.

According to a study titled “Epidemiology of Congenital Heart Disease in Jinan, China From 2005 to 2020: A Time Trend Analysis,” published in April 2022, the total CHD prevalence was 3.92 per 1,000 births in Jinan. In urban regions, from 2005 to 2020, the prevalence of CHD was 4.81 per 1,000 births compared to 3.17 per 1,000 births in rural areas. The CHD prevalence grew by 157.4% and 316.1% in urban and rural areas, respectively, during 2005–2020.

As per the Department of Health and Aged Care, 300,000 newborn babies are screened every year in Australia. Newborn bloodspot screening programs are delivered at state and territory levels. The Australian government helps fund these programs through the National Health Reform Agreement. Therefore, the above-mentioned factors are likely to play a major role in boosting the growth of the newborn screening market in Asia -Pacific.

Medtronic Plc, LifeCell International Pvt Ltd, Zentech SA, Trivitron Healthcare, PerkinElmer Inc, Waters Corp, Bio-Rad Laboratories Inc, Masimo Corp, Natus Medical Inc, Baebies Inc, and MRC Holland BV are among the leading companies operating in the newborn screening market.

Newborn Screening Market, by Region, 2022(%)

Source:the research team Analysis

Based on product type, the newborn screening market is segmented into reagents and assay kits and instruments. In terms of technology, the newborn screening market is segmented into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assays, pulse oximetry screening technology, and other technologies. Based on test type, the newborn screening market is segmented into dry blood spot tests, hearing screen tests, critical congenital heart disease tests, and other tests. Based on end user, the newborn screening market is segmented into hospitals and clinics, and diagnostic laboratories. By geography, the newborn screening market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Newborn Screening Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Newborn Screening Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Government Funding for Newborn Screening
5.1.2 Rising Burden of Congenital Diseases
5.1.3 Increasing Prevalence of Newborn Disorders
5.2 Key Market Restraints
5.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
5.3 Key Market Opportunities
5.3.1 Genetic Screening of Newborns
5.4 Future Trends
5.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
5.5 Impact Analysis:
6. Newborn Screening Market – Global Market Analysis
6.1 Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
7. Global Newborn Screening Market – Revenue and Forecast to 2030 – by Product Type
7.1 Overview
7.2 Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
7.3 Reagents and Assay Kits
7.3.1 Overview
7.3.2 Reagents and Assay Kits: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Global Newborn Screening Market, by Reagents and Assay Kits, 2020–2030 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Global Newborn Screening Market, by Instruments, 2020–2030 (US$ Million)
8. Global Newborn Screening Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Tandem Mass Spectrometry (TMS)
8.3.1 Overview
8.3.2 Tandem Mass Spectrometry (TMS): Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Molecular Assays
8.4.1 Overview
8.4.2 Molecular Assays: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Immunoassays and Enzymatic Assays
8.5.1 Overview
8.5.2 Immunoassays and Enzymatic Assays: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Pulse Oximetry Screening Technology
8.6.1 Overview
8.6.2 Pulse Oximetry Screening Technology: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Other Technologies
8.7.1 Overview
8.7.2 Other Technologies: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Newborn Screening Market – Revenue and Forecast to 2030 – by Test Type
9.1 Overview
9.2 Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
9.3 Dry Blood Spot Test
9.3.1 Overview
9.3.2 Dry Blood Spot Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Hearing Screen Test
9.4.1 Overview
9.4.2 Hearing Screen Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Critical Congenital Heart Diseases (CCHD) Test
9.5.1 Overview
9.5.2 Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Other Test Types
9.6.1 Overview
9.6.2 Other Test Types: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Newborn Screening Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
11. Newborn Screening Market – Geographical Analysis
11.1 North America Newborn Screening Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.1.3.1 North America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.1.3.2 North America: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.1.4 North America: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.1.5 North America: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.1.6 North America: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.1.6.1 North America Newborn Screening Market, by Country
11.1.6.2 US
11.1.6.2.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.2.2 US: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.1.6.2.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.1.6.2.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.1.6.2.3 US: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.1.6.2.4 US: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.1.6.2.5 US: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.1.6.3 Canada
11.1.6.3.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.3.2 Canada: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.1.6.3.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.1.6.3.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.1.6.3.3 Canada: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.1.6.3.4 Canada: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.1.6.3.5 Canada: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.1.6.4 Mexico
11.1.6.4.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.4.2 Mexico: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.1.6.4.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.1.6.4.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.1.6.4.3 Mexico: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.1.6.4.4 Mexico: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.1.6.4.5 Mexico: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2 Europe Newborn Screening Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.3.1 Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.3.2 Europe: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.4 Europe: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.5 Europe: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6 Europe: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.1 Europe Newborn Screening Market, by Country
11.2.6.2 UK
11.2.6.2.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.2.2 UK: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.2.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.2.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.2.3 UK: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.2.4 UK: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.2.5 UK: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.3 Germany
11.2.6.3.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.3.2 Germany: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.3.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.3.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.3.3 Germany: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.3.4 Germany: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.3.5 Germany: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.4 France
11.2.6.4.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.4.2 France: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.4.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.4.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.4.3 France: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.4.4 France: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.4.5 France: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.5 Italy
11.2.6.5.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.5.2 Italy: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.5.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.5.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.5.3 Italy: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.5.4 Italy: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.5.5 Italy: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.6 Spain
11.2.6.6.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.6.2 Spain: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.6.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.6.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.6.3 Spain: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.6.4 Spain: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.6.5 Spain: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.2.6.7 Rest of Europe
11.2.6.7.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.7.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.2.6.7.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.2.6.7.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.2.6.7.3 Rest of Europe: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.2.6.7.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.2.6.7.5 Rest of Europe: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.3.1 Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.3.2 Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.1 Asia Pacific Newborn Screening Market, by Country
11.3.6.2 China
11.3.6.2.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.2.2 China: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.2.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.2.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.2.3 China: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.2.4 China: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.2.5 China: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.3 Japan
11.3.6.3.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.3.2 Japan: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.3.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.3.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.3.3 Japan: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.3.4 Japan: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.3.5 Japan: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.4 India
11.3.6.4.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.4.2 India: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.4.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.4.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.4.3 India: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.4.4 India: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.4.5 India: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.5 Australia
11.3.6.5.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.5.2 Australia: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.5.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.5.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.5.3 Australia: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.5.4 Australia: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.5.5 Australia: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.6 South Korea
11.3.6.6.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.6.2 South Korea: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.6.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.6.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.6.3 South Korea: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.6.4 South Korea: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.6.5 South Korea: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.3.6.7 Rest of Asia Pacific
11.3.6.7.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.7.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.3.6.7.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.3.6.7.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.3.6.7.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.3.6.7.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.3.6.7.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4 Middle East & Africa Newborn Screening Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.3.1 Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.3.2 Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4.6.1 Middle East & Africa Newborn Screening Market, by Country
11.4.6.2 Saudi Arabia
11.4.6.2.1 Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.2.2 Saudi Arabia: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.6.2.2.1 Saudi Arabia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.6.2.2.2 Saudi Arabia: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.6.2.3 Saudi Arabia: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.6.2.4 Saudi Arabia: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6.2.5 Saudi Arabia: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4.6.3 UAE
11.4.6.3.1 UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.3.2 UAE: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.6.3.2.1 UAE: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.6.3.2.2 UAE: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.6.3.3 UAE: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.6.3.4 UAE: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6.3.5 UAE: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4.6.4 South Africa
11.4.6.4.1 South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.4.2 South Africa: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.6.4.2.1 South Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.6.4.2.2 South Africa: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.6.4.3 South Africa: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.6.4.4 South Africa: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6.4.5 South Africa: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.4.6.5 Rest of Middle East & Africa
11.4.6.5.1 Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.5.2 Rest of Middle East & Africa: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.4.6.5.2.1 Rest of Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.4.6.5.2.2 Rest of Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.4.6.5.3 Rest of Middle East & Africa: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.4.6.5.4 Rest of Middle East & Africa: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.4.6.5.5 Rest of Middle East & Africa: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America Newborn Screening Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.5.3.1 South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.5.3.2 South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.5.4 South & Central America: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.5.5 South & Central America: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.5.6 South & Central America: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.5.6.1 South & Central America Newborn Screening Market, by Country
11.5.6.2 Brazil
11.5.6.2.1 Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.2.2 Brazil: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.5.6.2.2.1 Brazil: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.5.6.2.2.2 Brazil: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.5.6.2.3 Brazil: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.5.6.2.4 Brazil: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.5.6.2.5 Brazil: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.5.6.3 Argentina
11.5.6.3.1 Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.3.2 Argentina: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.5.6.3.2.1 Argentina: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.5.6.3.2.2 Argentina: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.5.6.3.3 Argentina: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.5.6.3.4 Argentina: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.5.6.3.5 Argentina: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
11.5.6.4 Rest of South & Central America
11.5.6.4.1 Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.4.2 Rest of South & Central America: Newborn Screening Market, by Product Type, 2020–2030 (US$ Million)
11.5.6.4.2.1 Rest of South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020–2030 (US$ Million)
11.5.6.4.2.2 Rest of South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020–2030 (US$ Million)
11.5.6.4.3 Rest of South & Central America: Newborn Screening Market, by Technology, 2020–2030 (US$ Million)
11.5.6.4.4 Rest of South & Central America: Newborn Screening Market, by Test Type, 2020–2030 (US$ Million)
11.5.6.4.5 Rest of South & Central America: Newborn Screening Market, by End User, 2020–2030 (US$ Million)
12. Newborn Screening Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in Newborn Screening Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 LifeCell International Pvt Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Zentech SA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Trivitron Healthcare Pvt Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Waters Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio-Rad Laboratories Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Masimo Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Natus Medical Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Baebies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 MRC Holland BV
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Medtronic Plc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Newborn Screening Market Segmentation
Table 2. Global Newborn Screening Market, by Reagents and Assay Kits – Revenue and Forecast to 2030 (US$ Million)
Table 3. Global Newborn Screening Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. North America Newborn Screening Market, by Test Type– Revenue and Forecast to 2030 (US$ Million)
Table 9. North America Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. US Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. US Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. US Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. US Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 14. US Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. US Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 20. Canada Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. Canada Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 26. Mexico Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. Mexico Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 32. Europe Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. Europe Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 34. UK Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 35. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 36. UK Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 37. UK Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 38. UK Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 39. UK Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 40. Germany Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 41. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 42. Germany Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 43. Germany Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 44. Germany Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 45. Germany Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 46. France Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 47. France Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 48. France Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 49. France Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 50. France Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 51. France Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 56. Italy Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 57. Italy Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 62. Spain Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 63. Spain Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Europe Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Europe Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 74. Asia Pacific Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 75. Asia Pacific Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 76. China Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 77. China Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 78. China Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 79. China Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 80. China Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 81. China Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 86. Japan Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 87. Japan Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 88. India Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 89. India Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 90. India Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 91. India Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 92. India Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 93. India Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 98. Australia Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 99. Australia Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 | (US$ Million)
Table 103. South Korea Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 104. South Korea Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 105. South Korea Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 110. Rest of Asia Pacific Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 111. Rest of Asia Pacific Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 116. Middle East & Africa Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 117. Middle East & Africa Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 118. Saudi Arabia Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 119. Saudi Arabia Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 120. Saudi Arabia Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 121. Saudi Arabia Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 124. UAE Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 125. UAE Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 126. UAE Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 127. UAE Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 128. UAE Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 129. UAE Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 130. South Africa Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 131. South Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 132. South Africa Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 133. South Africa Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 134. South Africa Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 135. South Africa Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 140. Rest of Middle East & Africa Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 141. Rest of Middle East & Africa Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 146. South & Central America Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 147. South & Central America Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 152. Brazil Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 153. Brazil Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 158. Argentina Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 159. Argentina Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 164. Rest of South & Central America Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 165. Rest of South & Central America Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 166. Recent Organic Growth Strategies in Newborn Screening Market
Table 167. Recent Inorganic Growth Strategies in the Newborn Screening Market
Table 168. Glossary of Terms, Newborn Screening Market

LIST OF FIGURES

Figure 1. Newborn Screening Market Segmentation, By Geography
Figure 2. Global – PEST Analysis
Figure 3. Newborn Screening Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Newborn Screening Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 8. Reagents and Assay Kits: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Instruments: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 11. Tandem Mass Spectrometry (TMS): Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Assays: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Immunoassays and Enzymatic Assays: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Pulse Oximetry Screening Technology: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Other Technologies: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 17. Dry Blood Spot Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Hearing Screen Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Other Test Types: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Hospitals and Clinics: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Laboratories: Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: Newborn Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. North America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 27. US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Europe Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 31. Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 33. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Asia Pacific Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 40. Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 42. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Middle East & Africa Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 49. Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Middle East & Africa Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 51. Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 56. South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. South & Central America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 58. Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Growth Strategies in Newborn Screening Market

The List of Companies – Newborn Screening Market
– LifeCell International Pvt Ltd
– Zentech SA
– Trivitron Healthcare Pvt Ltd
– PerkinElmer Inc
– Waters Corp
– Bio-Rad Laboratories Inc.
– Masimo Corp
– Natus Medical Inc.
– Baebies Inc
– MRC Holland BV
– Medtronic Plc

Reviews

There are no reviews yet.

Be the first to review “Newborn Screening Market Size and Forecasts (2020 – 2030)”